EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double‐blind, placebo‐controlled study)

Jin Pyo Hong iD, Akramul Zikri Abd Malek iD, Cheng-Ta Li iD, Jong-Woo Paik iD, Ahmad Hatim Sulaiman iD, Gilbert Madriaga, Jianmin Zhuo iD, Sarah Siggins iD, Dong-Jing Fu iD, Po-Chung Ju iD

Asia-Pacific Psychiatry · 2023

DOI: 10.1111/appy.12548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Psychiatry, 2023. Verfasst von Jin Pyo Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Samsung Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Janssen Asia Pacific.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This post‐hoc analysis evaluated the efficacy and safety of intranasal esketamine in the Asian subgroup from ASPIRE I. Patients with major depressive disorder and suicidal ideation with intent received intranasal esketamine ( n = 26) or placebo ( n = 27), plus standard of care for 25 days. The primary endpoint was the change in Montgomery‐Åsberg Depression Rating Scale (MADRS) total score from baseline to Day 2. The MADRS score improved in favor of esketamine (least squares mean difference: −3.8). No unexpected safety concerns were noted. The Asian subgroup showed a similar efficacy and safety profile as the total ASPIRE I cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDepressive Disorder, Treatment-ResistantHumansAntidepressive AgentsDouble-Blind MethodNasal SpraysStandard of CareSuicidal IdeationTreatment OutcomeKetamine

Stichwörter der Autor:innen

Asianintranasal esketaminemajor depressive disordersuicide

Substanzen

Antidepressive AgentsNasal SpraysEsketamineKetamine

Autor:innen und Institutionen

  • Department of Psychiatry, Samsung Medical Center, Seoul, Republic of Korea.
  • Department of Psychiatry and Mental Health, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
  • Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Division of Psychiatry, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Institute of Brain Science and Brain Research Center, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Psychiatry, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.

ORCID-Profile: Jin Pyo Hong, Akramul Zikri Abd Malek, Cheng-Ta Li, Jong-Woo Paik, Ahmad Hatim Sulaiman, Jianmin Zhuo, Sarah Siggins, Dong-Jing Fu, Po-Chung Ju

Förderung

  • Janssen Asia Pacific

Zitieren

APA

Hong, J. P., Malek, A. Z. A., Li, C. T., Paik, J. W., Sulaiman, A. H., Madriaga, G., Zhuo, J., Siggins, S., Fu, D. J., & Ju, P. C. (2023). Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double‐blind, placebo‐controlled study). Asia-Pacific Psychiatry. https://doi.org/10.1111/appy.12548

Vancouver

Hong JP, Malek AZA, Li CT, Paik JW, Sulaiman AH, Madriaga G, et al. Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double‐blind, placebo‐controlled study). Asia-Pacific Psychiatry. 2023. doi:10.1111/appy.12548

BibTeX
@article{Hong2023,
  author = {Hong, Jin Pyo and Malek, Akramul Zikri Abd and Li, Cheng-Ta and Paik, Jong-Woo and Sulaiman, Ahmad Hatim and Madriaga, Gilbert and Zhuo, Jianmin and Siggins, Sarah and Fu, Dong-Jing and Ju, Po-Chung},
  title = {Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double‐blind, placebo‐controlled study)},
  journal = {Asia-Pacific Psychiatry},
  year = {2023},
  doi = {10.1111/appy.12548}
}
Kostenlos starten →